SENSEX
NIFTY
GOLD
USD/INR

Weather

image 29    C

National News

The Economic Times

National / The Economic Times

details

Eli Lillys Mounjaro wins FDA approval for a major new cardiovascular benefit

Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes and weight management. The drug demonstrated an 8% greater reduction in cardiovascular events in a key study. Mounjaro's approval strengthens Eli Lilly's position in the GLP-1 medicine market. This development highlights the expanding medical potential of these widely used drugs.

28 Aug 2026 11:42 pm